Wird geladen...
Combination therapy with vedolizumab and etanercept in a patient with pouchitis and spondylarthritis
Inflammatory bowel disease is frequently associated with spondylarthritis (SpA). It has been discussed that α4/β7 expressing lymphocytes are involved in the aetiology of SpA. We report a case of a successful combination therapy of vedolizumab (VDZ) and etanercept (ETA) in a patient with ulcerative c...
Gespeichert in:
| Veröffentlicht in: | BMJ Open Gastroenterol |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5306500/ https://ncbi.nlm.nih.gov/pubmed/28243458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2016-000127 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|